Alzheimer's Disease Trial, Recruiting NCT06501495 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06501495
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are male or female and have signed a consent form agreeing to take part
  • You are covered by a social security (health insurance) system
  • You are a native French speaker
  • You have completed at least 9th grade level of schooling (at least 7 years of education)

If you are a patient with early-stage Alzheimer's disease:

  • You are between 60 and 85 years old
  • You have been diagnosed with early (prodromal) Alzheimer's disease, confirmed by memory problems and at least one of the following tests: a spinal fluid test, a special brain scan (amyloid PET), or a blood test showing Alzheimer's markers

If you are an older adult without memory problems:

  • You are between 60 and 85 years old
  • You have been found to have healthy cognition based on three standard memory and thinking tests (confirm with trial site for exact score requirements)

If you are a younger adult without memory problems:

  • You are between 18 and 35 years old
  • You have been found to have healthy cognition based on three standard memory and thinking tests (confirm with trial site for exact score requirements)

Who may not be able to join:

  • Anyone who does not meet the inclusion criteria listed above may not be eligible (confirm with trial site for full exclusion details, as none were explicitly listed in the source criteria)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marc Teichmann, MD, assisitance publique Hôpitaux de paris

Phone: 01 42 16 75 34

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 April 2025
Est. completion
1 April 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

slow waves density

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov